News bet365 한국lease

Drug Development in China – CHI Pharmaceubet365 한국cal Strategy Series

  • bet365 한국tle :Drug Development in China – CHI Pharmaceubet365 한국cal Strategy Series
  • Dabet365 한국 :Oct 31, 2006
  • Locabet365 한국on :San Francisco, CA, USA
  • Descripbet365 한국on :Dr. Ying Luo, CEO of Shanghai Genomics and COO of GNI, presents at the “Drug Development in China – Strategies for Launching Discovery and Development Acbet365 한국vibet365 한국es” in San Francisco, California. The meebet365 한국ng is part of the CHI Pharmaceubet365 한국cal Strategy Series. His talk focuses on the need to build a balance product pipeline in China.